HRES. 803In Committee
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Urges the Food and Drug Administration Director to reevaluate the safety of chemical abortion drugs using recent independent studies
Plain-English overview
What this bill does
Urges the Food and Drug Administration Director to reevaluate the safety of chemical abortion drugs using recent independent studies
Key points
- Direct reevaluation of chemical abortion drugs
Current status
Where it stands
Status
In Committee
Latest action
2025-10-10 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedHealth
